Evidence map›Paper›PMID 35542203›Full record

ArticleRSC advances2018

Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools.

Sameek Singh, Samantha L Cooper, Jacqueline R Glenn, Jessica Beresford, Lydia R Percival, Joel D A Tyndall, Stephen J Hill, Laura E Kilpatrick, Andrea J Vernall

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Sameek SinghSchool of Pharmacy, University of Otago PO Box 56 Dunedin 9054 New Zealand andrea.vernall@otago.ac.nz +64 3 479 4518.
Samantha L CooperPhysiology, Pharmacology and Neuroscience Division, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.
Jacqueline R GlennPhysiology, Pharmacology and Neuroscience Division, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.
Jessica BeresfordPhysiology, Pharmacology and Neuroscience Division, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.
Lydia R PercivalPhysiology, Pharmacology and Neuroscience Division, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.
Joel D A TyndallSchool of Pharmacy, University of Otago PO Box 56 Dunedin 9054 New Zealand andrea.vernall@otago.ac.nz +64 3 479 4518.ORCID https://orcid.org/0000-0003-0783-1635
Stephen J HillPhysiology, Pharmacology and Neuroscience Division, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.
Laura E KilpatrickPhysiology, Pharmacology and Neuroscience Division, School of Life Sciences, University of Nottingham Nottingham NG7 2UH UK.
Andrea J VernallSchool of Pharmacy, University of Otago PO Box 56 Dunedin 9054 New Zealand andrea.vernall@otago.ac.nz +64 3 479 4518.ORCID https://orcid.org/0000-0001-8056-0726
University of Nottingham · GBUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) constitute the largest family of transmembrane receptors in eukaryotes. The adenosine A

Identifiers

PMID35542203
PMCPMC9080270
OpenAlexW2801838455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.